Sensorygen
Sean Boyle has extensive experience in the field of bioinformatics, with a focus on cancer and immuno-oncology solutions. Sean held various roles at Personalis, Inc., including Executive Director of Bioinformatics Science, Senior Director of Bioinformatics Applications, Director of Bioinformatics Applications, and Manager of Bioinformatics Applications. In these positions, they led teams in the development of novel DNA, RNA, and ctDNA applications for clinical diagnostics, neoantigen detection, characterization of biomarkers for immunotherapy, and profiling the tumor microenvironment. Prior to their time at Personalis, Sean co-founded Sensorygen, where they contributed to the research and development of olfactory-based insect repellents. Sean also served as a Postdoctoral Researcher at Stanford University, focusing on genome sequencing and individual diagnosis and treatment. Sean completed their doctoral studies at the University of California, Riverside, where they developed a method to predict ligands for odor receptors in Drosophila. Additionally, they worked as an Associate Instructor and Researcher at Indiana University Bloomington and as an intern at Eli Lilly, where they designed an automated image analysis algorithm for neuronal necrosis identification.
Sean Boyle received their Master of Science degree in Bioinformatics from Indiana University Bloomington in 2007. Sean then pursued their PhD in Bioinformatics, Chemical Informatics, and Genetics at the University of California, Riverside from 2007 to 2012. Following their PhD, Boyle joined Stanford University as a Postdoctoral Researcher in the field of Personalized Genomic Medicine from 2012 to 2014.
This person is not in any teams
This person is not in any offices
Sensorygen
1 followers
Sensorygen discover natural compounds to replace toxic/harsh chemicals in products through computational biology. Approximately 1 billion people are at risk of insect bites and transmitted diseases, while 30% of the global agricultural output is destroyed by insects. Altogether this represents nearly a trillion dollars in loss each year. Thecompany focus is to use cutting edge research toward finding effective and safe insect repellants. With their technology, they are building on a new generation of broad-spectrum insect repellents for protecting humans, their homes, their pets, stored products, and crops.A common problem inherent in the flavors and fragrances industry is the reliance on antiquated techniques in order to evaluate new odors for use in consumer products and evaluating the character of those odors using subjective descriptions. Sensorygen, eliminates much of the work and cost involved in evaluating small molecules using their highly accurate in silico screening platforms, narrowing down 400,000+ potential odor candidates to hundreds.The company was founded in 2013 by Dr. Anandasankar Ray.